Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_provenance.
- NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_assertion description "[We reported previously that treatment with all-trans retinoic acid (ATRA) and granulocyte macrophage colony-stimulating factor (GM-CSF) induces differentiation of human myeloblastic leukemia ML-1 cells to granulocytes, whereas treatment with ATRA alone induces practically no differentiation of these cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_provenance.
- NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_assertion evidence source_evidence_literature NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_provenance.
- NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_assertion SIO_000772 10969805 NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_provenance.
- NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_assertion wasDerivedFrom befree-20150227 NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_provenance.
- NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_assertion wasGeneratedBy ECO_0000203 NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_provenance.
- befree-20150227 importedOn "2015-02-27" NP331450.RANcA_oONw4UhIMEwGi3CbOVrHxhJSaIwKbSrdyHizAR4130_provenance.